Human lymphocyte antigen DR7 protects against proliferative retinopathy with type II diabetes mellitus

Arch Med Res. 2002 Mar-Apr;33(2):123-7. doi: 10.1016/s0188-4409(01)00378-2.

Abstract

Background: This study was undertaken in order to analyze the genetic incidence of human lymphocyte antigen diabetic retinopathy (HLA-DR) and its influence in proliferative diabetic retinopathy (PDR).

Methods: We designed a case-control study in which 127 mestizo Mexican patients with DM II and diabetic retinopathy were studied. DNA was extracted and HLA-DR regions were amplified using PCR. Alleles were determined by DNA hybridization. Diagnosis was assessed clinically and by fluorescein angiography. Incidence of HLA-DR alleles in patients was compared with an ethnically matched control group of healthy subjects (n = 98). Statistical significance was established with non-parametric tests.

Results: Patients with diabetic retinopathy showed less frequency of HLA-D11 compared with the control group (p = 0.043). NPDR patients with 10 or more years of DM II showed an increase of HLA-DR7 (p = 0.01).

Conclusions: Our results suggest that the presence of HLA-DR7 protects against the development of proliferative disease in the diabetic Mexican population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetes Mellitus, Type 2 / immunology
  • Diabetic Retinopathy / genetics*
  • Diabetic Retinopathy / immunology
  • Disease Progression
  • Female
  • Gene Frequency
  • HLA-DR7 Antigen / genetics
  • HLA-DR7 Antigen / immunology
  • HLA-DR7 Antigen / physiology*
  • Humans
  • Lymphocytes / immunology
  • Lymphocytes / metabolism
  • Male
  • Mexico
  • Middle Aged

Substances

  • HLA-DR7 Antigen